journal article·2025-05-13Open access

Berberine-Functionalized Bismuth-Doped Carbon Dots in a Pathogen-Responsive Hydrogel System: A Multifaceted Approach to Combating Periodontal Diseases

Xuan Li, Regina Huang, Pugeng Li, Fung Kit Tang, Jing He, Hanyu Sun, Xiaoyu Wang, Miao Wang, Xinmiao Lan, Xinna Wang, Sarah Sze Wah Wong, Lijian Jin, Ken Cham-Fai Leung, Hai Ming Wong, Sheng Wang, Lanping Guo, Pei-Hui Ding, Xiaolin Yu

ACS Nano· Volume 19· Issue 18

Abstract

High Resolution Image Download MS PowerPoint Slide Periodontal disease, a global health burden linked to dysbiotic oral polymicrobial communities and disrupted immune-inflammatory responses, is critically mediated by Porphyromonas gingivalis ( Pg )─the keystone pathogen that sabotages host immunity, triggers tissue inflammation and destruction, and disrupts microbiota balance. Effective therapies should combine antimicrobial action, immune modulation, virulence suppression, and microbiome restoration. Bismuth ions and berberine, which exhibit antimicrobial and epithelial barrier-protecting effects, show potential effectiveness in treating periodontal diseases but face practical limitations due to poor water solubility and bioavailability. To address this, we developed bismuth-doped carbon dots functionalized with structure-modified berberine (BiCD-Ber) as a multifunctional nanomedicine. BiCD-Ber eradicated Pg in various forms, restored Pg -perturbed immune responses in gingival fibroblasts, and preserved epithelial barrier integrity. The doped bismuth ions neutralized Pg virulence factors by blocking the catalytic sites of gingipains. To facilitate in vivo delivery, BiCD-Ber was encapsulated in a disulfide-modified hyaluronic acid hydrogel that degrades in response to Pg metabolites. This BiCD-Ber hydrogel system modulated subgingival microbiota, alleviated inflammation in gingiva, and thereby prevented alveolar bone loss. This approach to concurrently eliminating Pg, modulating inflammatory responses, suppressing virulence factors, and restoring microbiota showcases great potential in managing periodontitis effectively.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Oral microbiology and periodontitis research · Neonatal Health and Biochemistry · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Faculty of Dentistry

The University of Hong Kong

Hospital of Stomatology, Guanghua School of Stomatology, Guangdong Provincial Key Laboratory of Stomatology

Sun Yat-sen University

Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Engineering Research Centre of Ministry of Education of China, Beijing Laboratory of Biomedical Materials, School of Pharmaceutical Science

Capital Medical University

Department of Mechanical Engineering

Immunology of Fungal Infections Unit

Institut Pasteur

Department of Chemistry

The Hong Kong Baptist University

State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, National Resource Center for Chinese Materia Medica

China Academy of Chinese Medical Sciences

Stomatology Hospital, School of Stomatology, Zhejiang

University School of Medicine

Funding

Food and Health Bureau · National Natural Science Foundation of China

References (77)

Show source-provided references
1. 10.1016/S0140-6736(24)02811-310.1016/S0140-6736(24)02811-3 ↗
2. 10.1111/odi.1242810.1111/odi.12428 ↗
3. 10.3389/froh.2021.72546010.3389/froh.2021.725460 ↗
4. 10.1111/jcpe.1355410.1111/jcpe.13554 ↗
5. 10.1016/j.adaj.2022.12.01110.1016/j.adaj.2022.12.011 ↗
6. 10.3389/froh.2025.148894110.3389/froh.2025.1488941 ↗
7. 10.1111/prd.1237110.1111/prd.12371 ↗
8. 10.1038/nrmicro287310.1038/nrmicro2873 ↗
9. 10.1111/jcpe.1300210.1111/jcpe.13002 ↗
10. 10.1128/AAC.02529-1910.1128/AAC.02529-19 ↗
11. 10.1186/s12951-023-02261-y10.1186/s12951-023-02261-y ↗
12. 10.3389/fmicb.2022.102099510.3389/fmicb.2022.1020995 ↗
13. 10.1186/s12951-021-01175-x10.1186/s12951-021-01175-x ↗
14. 10.1111/hel.1314110.1111/hel.13141 ↗
15. 10.1038/s41564-020-00802-x10.1038/s41564-020-00802-x ↗
16. 10.1186/s42490-020-00044-210.1186/s42490-020-00044-2 ↗
17. 10.2217/nnm-2022-015310.2217/nnm-2022-0153 ↗
18. 10.3390/pharmaceutics1311179310.3390/pharmaceutics13111793 ↗
19. 10.1038/s41598-024-74273-z10.1038/s41598-024-74273-z ↗
20. 10.1021/acsnano.2c0575610.1021/acsnano.2c05756 ↗
21. 10.1021/acsapm.4c0218710.1021/acsapm.4c02187 ↗
22. 10.1039/c9mt00085b10.1039/c9mt00085b ↗
23. 10.3389/fmicb.2021.74812110.3389/fmicb.2021.748121 ↗
24. 10.1016/j.mtbio.2022.10050710.1016/j.mtbio.2022.100507 ↗
25. 10.1002/ptr.780610.1002/ptr.7806 ↗
26. 10.3389/fphar.2022.101504510.3389/fphar.2022.1015045 ↗
27. 10.1038/aps.2016.12510.1038/aps.2016.125 ↗
28. 10.2147/IDR.S43125610.2147/IDR.S431256 ↗
29. 10.2174/092986733066623020711253910.2174/0929867330666230207112539 ↗
30. 10.1007/s12079-022-00706-x10.1007/s12079-022-00706-x ↗
31. 10.1016/j.biopha.2019.10913110.1016/j.biopha.2019.109131 ↗
32. 10.7150/ijbs.6547610.7150/ijbs.65476 ↗
33. 10.1080/15384101.2022.210068210.1080/15384101.2022.2100682 ↗
34. 10.1016/j.ejphar.2019.02.02610.1016/j.ejphar.2019.02.026 ↗
35. 10.1111/jcmm.1701910.1111/jcmm.17019 ↗
36. Li T. · Int. J. Biomed. Eng. · 2023 · 23
37. 10.1039/C9QM00658C10.1039/C9QM00658C ↗
38. 10.1111/odi.1470210.1111/odi.14702 ↗
39. 10.1021/acsami.9b1800310.1021/acsami.9b18003 ↗
40. 10.1016/j.cej.2021.13310110.1016/j.cej.2021.133101 ↗
41. 10.1002/adhm.20200134110.1002/adhm.202001341 ↗
42. 10.3390/gels910083810.3390/gels9100838 ↗
43. 10.1002/adfm.20240549910.1002/adfm.202405499 ↗
44. 10.1002/adfm.20240338610.1002/adfm.202403386 ↗
45. 10.1002/adfm.20240912110.1002/adfm.202409121 ↗
46. 10.1039/C4NR04267K10.1039/C4NR04267K ↗
47. 10.1098/rsos.17214910.1098/rsos.172149 ↗
48. 10.1039/c2sm07236j10.1039/c2sm07236j ↗
49. 10.1039/D2CC01334G10.1039/D2CC01334G ↗
50. 10.1016/j.saa.2009.12.05010.1016/j.saa.2009.12.050 ↗
51. 10.3390/nano1224448210.3390/nano12244482 ↗
52. 10.1021/ja201327810.1021/ja2013278 ↗
53. 10.1038/s41579-022-00791-010.1038/s41579-022-00791-0 ↗
54. 10.1128/AEM.02750-0610.1128/AEM.02750-06 ↗
55. 10.1016/j.tim.2021.01.01010.1016/j.tim.2021.01.010 ↗
56. 10.1111/jre.1291510.1111/jre.12915 ↗
57. 10.1177/0022034523115192110.1177/00220345231151921 ↗
58. 10.1101/cshperspect.a01697210.1101/cshperspect.a016972 ↗
59. de Almeida M. S. · Chem. Soc. Rev. · 2021 · 50 · 539710.1039/D0CS01127D ↗
60. 10.1038/s41368-022-00215-y10.1038/s41368-022-00215-y ↗
61. 10.1002/sstr.20220003310.1002/sstr.202200033 ↗
62. 10.3389/fcimb.2023.128910310.3389/fcimb.2023.1289103 ↗
63. 10.1515/hsz-2018-021510.1515/hsz-2018-0215 ↗
64. 10.1186/1471-2180-13-15510.1186/1471-2180-13-155 ↗
65. 10.1159/00018114410.1159/000181144 ↗
66. 10.1111/j.1399-302X.2008.00467.x10.1111/j.1399-302X.2008.00467.x ↗
67. 10.1080/20002297.2023.220529110.1080/20002297.2023.2205291 ↗
68. 10.3390/ijms2405454410.3390/ijms24054544 ↗
69. 10.1128/spectrum.03288-2210.1128/spectrum.03288-22 ↗
70. 10.2174/138920303348703610.2174/1389203033487036 ↗
71. 10.2174/138920303348702710.2174/1389203033487027 ↗
72. 10.1039/D4DT00778F10.1039/D4DT00778F ↗
73. 10.1099/mic.0.00064010.1099/mic.0.000640 ↗
74. 10.1038/s41598-022-26497-010.1038/s41598-022-26497-0 ↗
75. 10.1186/s12967-020-02664-710.1186/s12967-020-02664-7 ↗
76. 10.1016/j.jdsr.2021.09.00510.1016/j.jdsr.2021.09.005 ↗
77. 10.1016/j.chom.2023.02.00910.1016/j.chom.2023.02.009 ↗